HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nepadutant Menarini Richerche.

Abstract
Menarini Richerche is developing nepadutant, an NK2 antagonist, for the potential treatment of asthma and irritable bowel syndrome. The compound is in phase IIa trials in Belgium and Sweden for both these indications [359518].
AuthorsA Ahluwalia
JournalCurrent opinion in investigational drugs (London, England : 2000) (Curr Opin Investig Drugs) Vol. 2 Issue 7 Pg. 919-22 (Jul 2001) ISSN: 1472-4472 [Print] England
PMID11757791 (Publication Type: Journal Article, Review)
Chemical References
  • Bronchodilator Agents
  • MEN 11420
  • Peptides, Cyclic
  • Receptors, Neurokinin-2
  • Neurokinin A
Topics
  • Animals
  • Asthma (drug therapy)
  • Bronchodilator Agents (chemical synthesis, pharmacology, therapeutic use)
  • Colonic Diseases, Functional (drug therapy)
  • Humans
  • Neurokinin A (metabolism, physiology)
  • Peptides, Cyclic (chemical synthesis, pharmacology, therapeutic use)
  • Receptors, Neurokinin-2 (antagonists & inhibitors)
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: